Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi (IST:ONCSM)
Turkey flag Turkey · Delayed Price · Currency is TRY
96.80
+4.50 (4.88%)
Feb 28, 2025, 10:00 AM GMT+3

IST:ONCSM Income Statement

Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Revenue
374.49347.24292.94127.99
Revenue Growth (YoY)
7.85%18.54%128.88%-
Cost of Revenue
235.97295.57192.2339.65
Gross Profit
138.5251.67100.7188.34
Selling, General & Admin
124.58116.7365.9215.73
Other Operating Expenses
8.5821.051.782.25
Operating Expenses
133.16137.7867.6917.97
Operating Income
5.36-86.1133.0170.37
Interest Expense
-34.84-14.25-2.03-2.61
Interest & Investment Income
17.0425.74-11.19
Currency Exchange Gain (Loss)
0.07-8.616.512.55
Other Non Operating Income (Expenses)
-38.46-54.43-37.17-0.18
EBT Excluding Unusual Items
-50.83-137.660.3281.32
Gain (Loss) on Sale of Investments
--0.36--
Legal Settlements
0.011.85-2.82-0.9
Pretax Income
-50.82-136.17-2.580.41
Income Tax Expense
8.35-20.9418.278.68
Net Income
-59.17-115.23-20.7671.73
Net Income to Common
-59.17-115.23-20.7671.73
Shares Outstanding (Basic)
2424120
Shares Outstanding (Diluted)
2424120
Shares Change (YoY)
-96.60%5025.57%-
EPS (Basic)
-2.48-4.83-1.71303.08
EPS (Diluted)
-2.48-4.83-1.71303.08
Free Cash Flow
85.66-36.9226.6740.76
Free Cash Flow Per Share
3.59-1.552.20172.23
Dividend Per Share
--0.415-
Gross Margin
36.99%14.88%34.38%69.02%
Operating Margin
1.43%-24.80%11.27%54.98%
Profit Margin
-15.80%-33.18%-7.09%56.05%
Free Cash Flow Margin
22.87%-10.63%9.10%31.85%
EBITDA
50.11-38.4465.6277.08
EBITDA Margin
13.38%-11.07%22.40%60.23%
D&A For EBITDA
44.7547.6632.616.71
EBIT
5.36-86.1133.0170.37
EBIT Margin
1.43%-24.80%11.27%54.98%
Effective Tax Rate
---10.80%
Source: S&P Capital IQ. Standard template. Financial Sources.